New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

about

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

Item

http://www.wikidata.org/entity/Q36712843

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

@ast

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

@en

type

Item

label

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

@ast

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

@en

prefLabel

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

@ast

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

@en

P1476

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents

@en

P2093

Rajendran Kuppusamy

http://www.w3.org/2001/XMLSchema#string

Sunil Kumar Killi

http://www.w3.org/2001/XMLSchema#string

Y Padmanabha Reddy

http://www.w3.org/2001/XMLSchema#string

P2860

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Privileged structures - dream or reality: preferential organization of azanaphthalene scaffold.

A comparison of the structure of echinomycin and triostin A complexed to a DNA fragment.

The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control.

Glucose conjugation for the specific targeting and treatment of cancer.

Advances in the development of new tuberculosis drugs and treatment regimens.

Recent advances in design of potential quinoxaline anti-infectives.

Synthesis of sugars embodying conjugated carbonyl systems and related triazole derivatives from carboxymethyl glycoside lactones. Evaluation of their antimicrobial activity and toxicity.

Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.

1-Allyl-3-methyl-3',5'-diphenyl-spiro-[quinoxaline-2(1H),2'(3'H)-[1,3,4]thia-diazole]

P304

6471352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/6471352

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Ramalingam Peraman

P577

2016-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297727654

http://www.w3.org/2001/XMLSchema#string

P698

27051530

http://www.w3.org/2001/XMLSchema#string

P932

4802037

http://www.w3.org/2001/XMLSchema#string